Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension
Completed
Daiichi Sankyo Inc.
Phase 3
2005-05-01
This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus
amlodipine in mild to severe hypertensive patients older than 18 years of age
Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension
Completed
Daiichi Sankyo, Inc.
Phase 3
2005-05-01
This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus
amlodipine in mild to severe hypertensive patients older than 18 years of age
Amlodipine as add-on to Olmesartan in Hypertension
Completed
Sankyo Pharma Gmbh
Phase 3
2005-04-01
Test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive
patients whose blood pressure is not adequately controlled with olmesartan alone.
Olmesartan as an add-on to Amlodipine in Hypertension
Completed
Sankyo Pharma Gmbh
Phase 3
2005-04-01
This study is to test the efficacy and safety of the combination of olmesartan and amlodipine
in hypertensive patients whose blood pressure is not adequately controlled with amlodipine
alone
Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension
Completed
Sankyo Pharma Gmbh
Phase 4
2006-03-01
This study is to assess the safety and efficacy of an add-on treatment algorithm with
olmesartan, hydrochlorothiazide and amlodipine in patients with mild to moderate
hypertension.
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension
Completed
Daiichi Sankyo Inc.
Phase 3
2008-05-01
To determine the effectiveness of four different strength combinations of three approved
anti-hypertension therapies (olmesartan medoxomil, amlodipine, and hydrochlorothiazide) for
lowering blood pressure.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
